AVEO Oncology Reminds Shareholders to Vote “FOR” Cash Transaction…
BOSTON, Jan. 3, 2023 (GLOBE NEWSWIRE) — AVEO Oncology (“AVEO”) AVEO, a commercial-stage oncology biopharmaceutical company dedicated to providing medicines that help cancer patients live